V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007009 | 220002725 | 1.56 | 0 | Palliative (P) | 2017-02-28 | 2017-03-05 | AML16 DA 3+10 | N | N | 220031493 | AML16 TRIAL |
| 220007010 | 220011560 | 1.91 | 76.1 | Curative (C) | 2017-09-23 | 2017-09-26 | Dasatinib | 02 | N | 220031496 | DASATINIB |
| 220007011 | 220002726 | null | 105.4 | Palliative (P) | 2016-06-29 | 2016-06-29 | Idarubicin+Tretinoin Spanish Crse1 | N | null | 220031497 | IDARUBICIN + TRETINOIN |
| 220007012 | 220002727 | 1.6 | 82.6 | Palliative (P) | 2013-07-06 | 2013-07-17 | CISPLATIN + GEMCITABINE | N | N | 220031499 | CISPLATIN + GEMCITABINE |
| 220007013 | 220011561 | 1.67 | 94.6 | Palliative (P) | 2014-04-12 | 2014-05-18 | AML16 Low Dose Cytarabine | N | N | 220031504 | AML16 TRIAL |
| 220007014 | 220002728 | 1.57 | 53.8 | Curative (C) | 2017-04-27 | 2017-05-11 | IDARUBICIN + TRETINOIN | 02 | N | 220031505 | IDARUBICIN + TRETINOIN |
| 220007015 | 220002729 | 1.44 | 54.1 | Palliative (P) | 2014-06-27 | 2014-06-27 | Cisplatin+Gemcitabine (gallbladder) | N | N | 220031506 | CISPLATIN + GEMCITABINE |
| 220007016 | 220002730 | null | 78 | Curative (C) | null | 2016-10-29 | AML 18 TRIAL | Y | N | 220031507 | AML18 TRIAL |
| 220007017 | 220002731 | 1.69 | 51.2 | Curative (C) | 2013-04-11 | 2013-04-18 | AML18 PILOT TRIAL | Y | N | 220031508 | PILOT TRIAL |
| 220007018 | 220002732 | 1.61 | 47.2 | Palliative (P) | 2018-05-22 | 2018-05-27 | Dasatinib | 2 | N | 220031509 | DASATINIB |
| 220007019 | 220002732 | null | 56.9 | Curative (C) | 2014-10-01 | 2014-10-06 | AML18 PILOT TRIAL | Y | null | 220031509 | PILOT TRIAL |
| 220007020 | 220016220 | null | 84.8 | Curative (C) | null | 2017-11-13 | AML 18 TRIAL | Y | N | 220031516 | AML18 TRIAL |
| 220007021 | 220002733 | 1.71 | 63 | Palliative (P) | 2014-04-09 | 2014-04-16 | Dasatinib | 02 | N | 220031519 | DASATINIB |
| 220007022 | 220002733 | 1.88 | 78.1 | Curative (C) | 2013-05-18 | 2013-05-20 | AML18 PILOT TRIAL | N | N | 220031519 | PILOT TRIAL |
| 220007023 | 220002734 | 1.75 | 89.9 | Curative (C) | null | 2013-05-10 | AML 18 TRIAL | N | N | 220031522 | AML18 TRIAL |
| 220007024 | 220002735 | 1.93 | 87 | Curative (C) | null | 2017-07-11 | AML 18 TRIAL | N | N | 220031524 | AML18 TRIAL |
| 220007025 | 220002736 | 1.6 | 51.6 | Curative (C) | 2017-10-28 | 2017-10-30 | AML 18 TRIAL | 2 | N | 220031525 | AML18 TRIAL |
| 220007027 | 220002738 | 1.8 | 70.4 | Palliative (P) | null | 2016-06-29 | CISPLATIN + GEMCITABINE | 2 | N | 220031527 | CISPLATIN + GEMCITABINE |
| 220007032 | 220002740 | 1.77 | 113 | Palliative (P) | 2017-11-09 | 2017-11-09 | CISPLATIN + GEMCITABINE | N | N | 220031533 | CISPLATIN + GEMCITABINE |
| 220007033 | 220002741 | 1.75 | 78.55 | Palliative (P) | 2014-11-30 | 2014-12-16 | GemCarbo Days 1+8 | N | N | 220031538 | GEMCARBO |
| 220007034 | 220011565 | 1.68 | 108 | Palliative (P) | null | 2013-03-10 | IDARUBICIN + TRETINOIN | 2 | N | 220031539 | IDARUBICIN + TRETINOIN |
| 220007036 | 220002743 | null | 77.2 | Palliative (P) | 2017-07-06 | 2017-07-20 | GemCarbo Days 1+8 | N | N | 220031544 | GEMCARBO |
| 220007037 | 220002743 | 1.73 | 44.9 | null | 2017-11-27 | 2017-12-16 | CISPLATIN + GEMCITABINE | 02 | N | 220031544 | CISPLATIN + GEMCITABINE |
| 220007038 | 220002743 | 1.68 | null | Palliative (P) | 2016-07-22 | 2016-08-01 | Carboplatin + Paclitaxel (weekly) | 02 | null | 220031544 | CARBOPLATIN + PACLITAXEL |
| 220007039 | 220002743 | 1.75 | 74 | Curative (C) | 2013-12-16 | 2013-12-23 | AML16 Low Dose Cytarabine | N | N | 220031544 | AML16 TRIAL |
| 220007040 | 220002744 | 1.6 | null | Curative (C) | null | 2015-09-07 | AML 18 TRIAL | Y | N | 220031551 | AML18 TRIAL |
| 220007041 | 220002744 | 0 | 85.3 | Palliative (P) | 2014-06-28 | 2014-07-03 | AML16 DA 3+10 | N | N | 220031551 | AML16 TRIAL |
| 220007042 | 220002744 | 1.87 | 70.4 | Palliative (P) | 2013-09-14 | 2013-10-01 | Carboplatin + Paclitaxel (weekly) | N | N | 220031551 | CARBOPLATIN + PACLITAXEL |
| 220007043 | 220002744 | null | 88 | Palliative (P) | 2016-10-31 | 2016-10-31 | GemCarbo Days 1+8 | N | null | 220031551 | GEMCARBO |
| 220007044 | 220002744 | 1.67 | 72.5 | Curative (C) | 2014-04-07 | 2014-05-15 | AML16 Low Dose Cytarabine | N | N | 220031551 | AML16 TRIAL |
| 220007045 | 220002744 | 1.76 | 87.7 | Curative (C) | 2014-01-12 | 2014-01-21 | AML18 PILOT TRIAL | Y | N | 220031551 | PILOT TRIAL |
| 220007046 | 220002745 | 1.82 | 51.5 | Palliative (P) | null | 2014-07-25 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220031564 | CARBOPLATIN + PACLITAXEL |
| 220007047 | 220002745 | 1.61 | 0 | Disease modification (D) | 2013-09-24 | 2013-09-26 | IDARUBICIN + TRETINOIN | 2 | N | 220031564 | IDARUBICIN + TRETINOIN |
| 220007048 | 220002746 | 1.7 | 55.2 | Palliative (P) | 2017-10-30 | 2017-10-30 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031566 | CARBOPLATIN + PACLITAXEL |
| 220007049 | 220002746 | null | 127 | Palliative (P) | 2014-02-23 | 2014-04-18 | CISPLATIN + GEMCITABINE | null | N | 220031566 | CISPLATIN + GEMCITABINE |
| 220007050 | 220002746 | 1.62 | 58 | Curative (C) | 2013-01-22 | 2013-01-22 | Idarubicin+Tretinoin Spanish Crse2 | 2 | N | 220031566 | IDARUBICIN + TRETINOIN |
| 220007051 | 220002747 | 1.65 | 95 | Palliative (P) | 2013-03-09 | 2013-03-31 | CARBOPLATIN + GEMCITABINE | N | null | 220031580 | GEMCARBO |
| 220007052 | 220002747 | null | 84.8 | Palliative (P) | 2014-12-29 | 2015-01-20 | CISPLATIN + GEMCITABINE | N | N | 220031580 | CISPLATIN + GEMCITABINE |
| 220007053 | 220002747 | 1.68 | 59.9 | Curative (C) | 2013-06-09 | 2013-06-16 | IDARUBICIN + TRETINOIN | null | N | 220031580 | IDARUBICIN + TRETINOIN |
| 220007054 | 220002748 | 1.65 | 138.8 | Palliative (P) | 2016-02-27 | 2016-03-08 | AML16 DA 3+8 | Y | N | 220031588 | AML16 TRIAL |
| 220007055 | 220002748 | 1.79 | 77 | Curative (C) | null | 2016-02-12 | AML 18 TRIAL | 01 | N | 220031588 | AML18 TRIAL |
| 220007056 | 220002749 | 1.78 | 68.4 | Palliative (P) | 2017-02-09 | 2017-03-07 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031591 | CARBOPLATIN + PACLITAXEL |
| 220007057 | 220002750 | null | 108.7 | Palliative (P) | 2015-08-22 | 2015-08-30 | GemCarbo Days 1+8 | N | N | 220031592 | GEMCARBO |
| 220007058 | 220002751 | 1.51 | 95 | Curative (C) | 2016-03-22 | 2016-04-11 | Carboplatin + Paclitaxel (weekly) | null | N | 220031594 | CARBOPLATIN + PACLITAXEL |
| 220007059 | 220002752 | null | 95 | Adjuvant (A) | 2014-05-01 | 2014-05-26 | CARBOPLATIN + PACLITAXEL | N | N | 220031596 | CARBOPLATIN + PACLITAXEL |
| 220007060 | 220002752 | 1.65 | 49 | Curative (C) | 2016-05-30 | 2016-05-30 | AML18 PILOT TRIAL | Y | null | 220031596 | PILOT TRIAL |
| 220007061 | 220002752 | 1.74 | null | Palliative (P) | 2014-05-15 | 2014-05-15 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220031596 | IDARUBICIN + TRETINOIN |
| 220007062 | 220002752 | 1.63 | null | Curative (C) | 2013-02-14 | 2013-02-21 | AML16 Low Dose Cytarabine | Y | N | 220031596 | AML16 TRIAL |
| 220007063 | 220002752 | 1.71 | 72.5 | Palliative (P) | null | 2015-11-19 | Idarubicin+Tretinoin Spanish Crse4 | N | N | 220031596 | IDARUBICIN + TRETINOIN |
| 220007064 | 220002752 | 1.76 | 62.3 | Palliative (P) | 2015-06-08 | 2015-06-14 | IDARUBICIN + TRETINOIN | 2 | N | 220031596 | IDARUBICIN + TRETINOIN |